Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $432.77M.
ENTERPRISE VALUE (EV)
$432.77M
Bright Minds Biosciences Inc.
Market Cap
$492.29M
Enterprise Value (EV)
$432.77M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Bright Minds Biosciences Inc. (DRUG) | $492.29M | $432.77M |
| Evolus, Inc. (EOLS)vs › | $487.33M | $606.96M |
| NeoGenomics, Inc. (NEO)vs › | $502.08M | $804.91M |
| Cerus Corporation (CERS)vs › | $479.49M | $538.31M |
| Contineum Therapeutics, Inc. (CTNM)vs › | $479.41M | $471.27M |
| Arvinas, Inc. (ARVN)vs › | $478.75M | $392.65M |
| Allogene Therapeutics, Inc. (ALLO)vs › | $514.28M | $546.01M |
| NRC Health (NRC)vs › | $468.76M | $555.46M |
| Kamada Ltd. (KMDA)vs › | $463.91M | $446.24M |
| Altimmune, Inc. (ALT)vs › | $521.19M | $493.89M |
Market Cap
$492.29M
Total Debt
$0.00
Cash
$59.53M
Enterprise Value
$432.77M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
